Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Program Chairs

Jonathan Barker, MD, FRCP, FRCPath
St John’s Institute of Dermatology
London, England, United Kingdom
IPC President

Jonathan Barker, MD, is Professor of Medical Dermatology at St John’s Institute of Dermatology, King’s College London and honorary consultant dermatologist at Guy’s and St. Thomas’s Hospitals specializing in complex hospital based medical dermatology. He is senior consultant in the severe psoriasis service and co-director of the Skin Therapy Research Unit which conducts academic and commercially sponsored clinical studies and trials.
Professor Barker is the current President of International Psoriasis Council having previously been a board member and chair of the scientific committee. He is a principal investigator in national and international consortia using genetic and multi-omic approaches to discover causal disease mechanisms, new drug targets and biomarkers of disease subtypes and outcomes to therapeutic interventions. These are being applied to important chronic skin diseases such as psoriasis, acne and eczema. Professor Barker has published over 300 peer-reviewed papers, authored and edited several books including the latest (9th) edition of Rook’s Textbook of Dermatology. Highly cited publications include those in the Lancet, Nature Genetics and New England Journal of Medicine. Professor Barker was head of department at the Institute of Dermatology 2002-2018 and course director of the Institute’s MSc Clinical Dermatology for overseas graduates. He is a past President of the European Dermatology Forum and the European Society for Dermatological Research. He is an honorary overseas member of several national dermatological associations including Denmark, France, Germany, Japan, and the USA.

Last Updated: Oct 04, 2018

Peter van de Kerkhof, MD, PhD, Chief Medical Officer
International Psoriasis Council
Amsterdam, Netherlands

Professor Peter van de Kerkhof served as head of the department Dermatology at the Radboud University Nijmegen Medical Centre, The Netherlands, since 1992 and is currently a Professor Emeritus there. He graduated in medicine from the Catholic University of Nijmegen in 1978 and trained in Dermatology at the St. Radboud Hospital, Nijmegen. In 1983 and in 1990 he completed his theses in the faculty of medicine and faculty of sciences resp. Between 1980 and 1984 he completed his training as a dermatologist. Research interests of Professor van de Kerkhof are psoriasis, disorders of keratinization, inflammation and clinical pharmacology of the skin. He has been president of major European Dermatological societies such as European Society of Dermatological Research and European Dermatology Forum. He is member of the editorial board of several international dermatological journals. He is an author or coauthor of more than 600 peer reviewed dermatological journals. He joined the IPC Staff as Chief Medical Officer in July 2018.

Last Updated: Jan 09, 2019

Program Faculty

Francesca Capon, PhD
Guy's Hospital
London, England, United Kingdom

Dr. Capon obtained a BSc in biological sciences (1992) and PhD in medical genetics (1999) from La Sapienza, University of Rome, Italy.  Her interest in the genetics of psoriasis brought her to the United Kingdom. She first moved to the University of Leicester as a Wellcome Trust Traveling Research Fellow (2001), then took on a Lectureship in human molecular genetics at University College London (2004). She joined King’s College London in 2006 as a lecturer, was promoted to senior lecturer in 2014, and to reader (associate professor) in 2018. Her main research interest is the genetic basis of psoriasis. In recent years, the Capon lab has been concentrating on two main research lines: the identification of disease genes in pustular forms of psoriasis and the role of interleukin-36 in the pathogenesis of pustular and plaque psoriasis. This research has been published in high-impact journals including the American Journal of Human Genetics, the Journal of Allergy and Clinical Immunology, and Science Translational Medicine.

Last Updated: Oct 09, 2018

Joel Gelfand, MD, MSCE
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States
IPC Board Member

Joel M. Gelfand MD MSCE is Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania’s Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy Treatment Center. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 260 scientific publications, editorials, reviews, and text book chapters (cited over 18,000 times, H index 60) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatic Disease, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s New Investigator Marjorie Bowman Award and the Lady Barbara Colyton’s Award for Autoimmune research, Penn’s Department of Biostatistics and Epidemiology’s epidemiology teaching award, NPF’s inaugural award for scientific achievement, and is an elected member of the American Society for Clinical Investigation. He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology’s Eugene M. Farber lecture and the American Academy of Dermatology’s Marion B. Sulzberger lecture. He has received grant support from NIH, FDA, PCORI, the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.

Last Updated: Jan 21, 2020

Christopher EM Griffiths, OBE, MD, FRCP, FMedSci
University of Manchester
Manchester, England, United Kingdom
IPC Board Member

Chris Griffiths qualified in Medicine from St Thomas’ Hospital Medical School, London. He trained in Dermatology at St Mary’s Hospital, London, and at the University of Michigan, USA. He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an honorary consultant dermatologist at Salford Royal NHS Foundation Trust. He founded the Manchester Dermatopharmacology Unit and Manchester Psoriasis Service in 1994. Chris is an NIHR Senior Investigator and Fellow of the Academy of Medical Sciences. He has published 650 Pubmed cited articles in scientific journals (h-index 94), and is Editor-in-Chief of Rook’s Textbook of Dermatology. Chris is a Past- President of the British Association of Dermatologists, is President-Elect of the European Society for Dermatological Research and a Past- President and co-founder of the International Psoriasis Council. He has long-standing research interests in all aspects of psoriasis and directs the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) and the MRC Psoriasis Stratification to Optimise Relevant Therapy (PSORT) consortium. Chris is a recipient of the Sir Archibald Gray Medal for services to British Dermatology and was appointed an Officer of the Order of the British Empire (OBE), for services to dermatology, in the Queen’s 2018 New Year’s Honours.

Last Updated: Sep 05, 2019

Arthur Kavanaugh, MD
Center for Innovative Therapy in the UCSD Division of Rheumatology
La Jolla, United States

Arthur Kavanaugh is Professor of Medicine at the University of California, San Diego (UCSD) School of Medicine in La Jolla, CA, USA; he is also the Director of the Center for Innovative Therapy in the UCSD Division of Rheumatology, Allergy, and Immunology.

Prof. Kavanaugh’s main research interest has been in clinical research, particularly translational aspects of rheumatology research. This has included work delineating the pathophysiology of rheumatic diseases as well as defining changes associated with novel immunomodulatory therapies. Although a focus has been on rheumatoid arthritis (RA) and psoriatic arthritis (PsA), he has conducted many studies in other autoimmune conditions, including systemic lupus erythematosus, ankylosing spondylitis, inflammatory bowel disease, and others. He has been involved in helping to create guidelines for the treatment and optimal care of patients with rheumatic diseases, including RA and PsA.

Prof. Kavanaugh was involved with the formation of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and is currently on the executive committee. He had been a board member of the CORRONA (Consortium of Rheumatology Researchers of North America) registry since its inception. Prof. Kavanaugh has authored more than 500 peer reviewed scientific publications and reviews and book chapters, as well as being on the editorial board of several journals. He is a fellow of the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Rheumatology (ACR)

Last Updated: Nov 21, 2019

Julia-Tatjana Maul,
University Hospital of Zurich
Zürich, Switzerland

Julia-Tatjana Maul is a board qualified Senior Dermatologist in the Clinic for Dermatology at the University Hospital of Zürich, Switzerland. Dr. Maul contributed to the initiation and is now the principal investigator of the Swiss Dermatology Network for Targeted Therapy (SDNTT) in Psoriasis of Zürich and has contributed to the Global Psoriasis Atlas (GPA) through a 3-month study of psoriasis epidemiology and access to healthcare for psoriasis patients in South America. In October 2019, Dr. Maul officially joined the GPA team as a medical coordinator. During her fellowship, Dr. Maul will collaborate with Claudia de la Cruz of Clinica Dermacross in Chile and Ricardo Romiti of the University of Sao Paulo in Brazil.

Last Updated: Jan 06, 2020

Alexander Navarini,
University Hospital of Basel
Basel, Switzerland

Alexander Navarini is chairman of the Department of Dermatology, University Hospital of Basel since 2018. He was elected professor of immunodermatology, deputy head of the outpatient clinic and head of the patch testing laboratory at the University of Zurich, as well as leading the clinics for hand eczema and work-related dermatology, psoriasis and acne. Prof. Alexander Navarini graduated from medical school at the University of Basel and Université Marie-Curie in Paris, France in 2002. Between 2003 and 2006 he completed a postgraduate course in Experimental Medicine and Biology and MD Ph.D. studies at the University of Zurich. His research focuses on next generation genetics and gene hunting, as well as visual detection of skin diseases. He has published over 130 peer-reviewed articles and several bookchapters. Alexander Navarini is currently Principal Investigator of the European Rare and Severe Psoriasis Network (ERASPEN) for harmonizing phenotype descriptions, as well as of several clinical trials and the Swiss psoriasis registry.

Last Updated: Mar 26, 2019

Catherine Smith, MD
St John's Institute of Dermatology, Guys and St Thomas's Hospitals
London, England, United Kingdom

Catherine is Professor of Dermatology and Therapeutics and Consultant Dermatologist at St John’s Institute of Dermatology, Kings College London and Guys and St Thomas’ Hospital.  She co-directs the Skin Therapy Research Unit, and is also a lead clinician in national specialised services for adults with severe psoriasis.

Her clinical and research interests focus on inflammatory skin disease and translational medicine, extending from biomarker discovery through to interventional studies (phase II-IV), and involve major national and international collaboration. 

She also has a major interest in guideline development and implementation in the UK and Europe, with the aim of bringing research findings into clinical practice.

Last Updated: Jan 25, 2018

Bruce Strober, MD, PhD
Central Connecticut Dermatology, Cromwell, CT and Yale University, Department of Dermatology
New Haven, Connecticut, United States
IPC Secretary/Treasurer

Bruce E. Strober, MD, PhD, is a Clinical Professor at Yale University, Department of Dermatology. He received his medical and graduate degrees from Columbia University College of Physicians and Surgeons in New York, NY, and completed his postgraduate training in dermatology at New York University in New York, NY. Dr. Strober is board certified by the American Board of Dermatology, a fellow of the American Academy of Dermatology, and a past member of the medical board of the National Psoriasis Foundation.  He is the Co-Scientific Director of the Corrona Psoriasis Registry and Editor-in-Chief of the Journal of Psoriasis and Psoriatic Arthritis. Dr. Strober has authored numerous journal articles and book chapters. He has also spoken extensively to both physician and patient audiences in the field of dermatology.

Last Updated: Sep 21, 2020

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK